Recombinant Human GTSF1 protein (ab180332)
Key features and details
- Expression system: Escherichia coli
- Purity: > 90% SDS-PAGE
- Tags: His tag N-Terminus
- Suitable for: MS, SDS-PAGE
Description
-
Product name
Recombinant Human GTSF1 protein -
Purity
> 90 % SDS-PAGE.
ab180332 is purified using conventional chromatography techniques. -
Expression system
Escherichia coli -
Accession
-
Protein length
Full length protein -
Animal free
No -
Nature
Recombinant -
-
Species
Human -
Sequence
MGSSHHHHHH SSGLVPRGSH MGSMEETYTD SLDPEKLLQC PYDKNHQIRA CRFPYHLIKC RKNHPDVASK LATCPFNARH QVPRAEISHH ISSCDDRSCI EQDVVNQTRS LRQETLAEST WQCPPCDEDW DKDLWEQTST PFVWGTTHYS DNNSPASNIV TEHKNNLASG MRVPKSLPYV LPWKNNGNAQ -
Predicted molecular weight
22 kDa including tags -
Amino acids
1 to 167 -
Tags
His tag N-Terminus -
Additional sequence information
(NP_653195).
-
Associated products
-
Related Products
Specifications
Our Abpromise guarantee covers the use of ab180332 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
-
Applications
Mass Spectrometry
SDS-PAGE
-
Mass spectrometry
MALDI-TOF -
Form
Liquid -
Concentration information loading...
Preparation and Storage
-
Stability and Storage
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
pH: 8.00
Constituents: 0.32% Tris HCl, 0.88% Sodium chloride, 20% Glycerol (glycerin, glycerine), 0.02% DTT
General Info
-
Alternative names
- Cue110
- Fam112b
- Family with sequence similarity 112 member B
see all -
Sequence similarities
Belongs to the UPF0224 (FAM112) family.
Contains 1 CHHC-type zinc finger. - Information by UniProt
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (0)
ab180332 has not yet been referenced specifically in any publications.